Your search history is turned on.
Date: April 22, 2024 Jurisdictions: Alberta, British Columbia, Ontario
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Aion Therapeutic Announces Proposed Non-Brokered Private Placement Offering of Units TORONTO, ONTARIO April 22, 2024 Aion Therapeutic Inc. (CSE: AION) (Aion Therapeutic or the Company) is pleased to announce that it plans to complete a...
Date: April 12, 2024 Jurisdictions: Alberta, British Columbia, Ontario
Microsoft Word - 75261464_2_AION - Toppen BAR 2024-04-12.docx April 12, 2024 Form 51-102F4 Business Acquisition Report This Business Acquisition Report has been prepared by Aion Therapeutic Inc. (the Company or Aion) regarding its acquisition of all of the issued and outstanding common shares of Toppen Health Inc. (Toppen) on December 15, 2023 (the Acqu...
Date: April 1, 2024 Jurisdictions: Alberta, British Columbia, Ontario
Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Rakesh Malhotra, Chief Financial Officer of Aion Therapeutic Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Aion Therapeutic Inc. (the issuer) for the interim pe...
Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Graham Simmonds, Chief Executive Officer of Aion Therapeutic Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Aion Therapeutic Inc. (the issuer) for the interim pe...
AION THERAPEUTIC INC. MANAGEMENTS DISCUSSION AND ANALYSIS FOR THE THREE AND NINE MONTHS ENDED JANUARY 31, 2024 Prepared as at April 1, 2024 - 2 - Management Discussion and Analysis The following Managements Discussion and Analysis (...
AION THERAPEUTIC INC. Unaudited Condensed Interim Consolidated Financial Statements For the Three and Nine Months Ended January 31, 2024 and 2023 1 AION THERAPEUTIC INC. Table of Contents ...
Date: January 2, 2024 Jurisdictions: Alberta, British Columbia, Ontario
Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Rakesh Malhotra, Chief Financial Officer of Aion Therapeutic Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Aion Therapeutic Inc. (the issuer) for the interim period ended October 31,...
Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Graham Simmonds, Chief Executive Officer of Aion Therapeutic Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Aion Therapeutic Inc. (the issuer) for the interim period ended October 31,...
AION THERAPEUTIC INC. MANAGEMENTS DISCUSSION AND ANALYSIS FOR THE THREE AND SIX MONTHS ENDED OCTOBER 31, 2023 Prepared as at January 2, 2024 - 2 - Management Discussion and Analysis The following Managements Discussion and Analysis ...
AION THERAPEUTIC INC. Unaudited Condensed Interim Consolidated Financial Statements For the Three and Six Months Ended October 31, 2023 and 2022 1 AION THERAPEUTIC INC. Table of Contents ...